The data uncover broad optimism as well as stark regional disparities and cultural obstacles in the West that must be ...

Bemdaneprocel will be studied in a sham-surgery controlled, double-blind trial that is expected to start in the first half of ...

Bayer now says it expects to make €3 billion ... results of the phase 3 ARASENS trial in the New England Journal of Medicine. The study showed that adding Nubeqa to standard therapy with anti ...

Bayer cut its full-year earnings target after a tough agricultural market hit its crop-science division, and said it heads ...

Leadership Strategist Dan Pontefract covers leadership and culture. Heike Prinz of Bayer's Board of Management recently articulated the company's predicament, stating, "Bayer is currently in a ...

According to The Wall Street Journal, Bayer started putting in the cotton ... More from Science We've all been there: reaching for the medicine cabinet with a splitting headache, opening the ...

As we usher in 2025, it’s the perfect time to prioritize health and wellness. Recently, Registered Dietitian & Nutritionist Kelly Bristow from Bayer, one of the country's largest life-sciences ...

The US company has said it is launching the Phase III trials in the first half of this year after Phase I talks with the US ...

Tryggvi Thorgeirsson, co-founder and CEO of SidekickHealth, said: “Bayer continues to be at the forefront in the transformation of medicine, and we are thrilled to partner with them to deliver ...